These findings can be explained by the previously reported evidence [20] of CD105 being preferentially expressed on active endothelial cells during the neo-angiogenic process, whereas pan-endothelial antigens such as CD31 are also expressed by stable vessels trapped inside the tumor. Here, PECAM1 is linked to neoplasm.